Cargando…

Personalized monitoring of drug therapy effectiveness based on high-throughput analysis of drugs utilization and inflammatory factors closed functional networks in cardiovascular pathogenesis pathologies

Detalles Bibliográficos
Autores principales:	Babak, Svetlana, Litvinova, Larisa, Patrushev, Maksim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125752/ http://dx.doi.org/10.1186/1878-5085-5-S1-A80

Ejemplares similares

Personalized Drug Dosage – Closing the Loop
por: Tucker, Geoffrey T
Publicado: (2016)

Bispectral index (BIS) monitoring of ICU patients on continuous infusion of sedatives and paralytics reduces sedative drug utilization and cost
por: Kaplan, LJ, et al.
Publicado: (2000)

Stability monitoring of some acetylcholinesterase reactivating drugs
por: Ram, Nazila, et al.
Publicado: (2011)

Utilizing traditional Chinese for the discovery of efficacious new drugs
por: Bender, Andreas
Publicado: (2012)

Possibilities for preventive and personalized therapy of cancer by drugs screening
por: Volchek, Igor V, et al.
Publicado: (2014)

Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
por: Mason, P, et al.
Publicado: (2002)

Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Business analysis and market potential of drug screening technology for preventive and personalized therapy
por: Volchek, Igor V, et al.
Publicado: (2014)

Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
por: Todosenko, Natalia, et al.
Publicado: (2022)

Identifying Small Molecule Compounds that Have Synergistic Effects With Cisplatin and Other Platinum Drugs Using High Throughput Matrix Screening
por: Al-Zubi, Layla, et al.
Publicado: (2022)

Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer’s Disease
por: Wang, Jun, et al.
Publicado: (2013)

Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs
por: Kithcart, Aaron, et al.
Publicado: (2017)

Utilization of multifrequency permittivity measurements in addition to biomass monitoring
por: Heinrich, Christoph, et al.
Publicado: (2011)

Utilization of multifrequency permittivity measurements in addition to biomass monitoring
por: Heinrich, Christoph, et al.
Publicado: (2011)

The relationship between utilization of mobile health technology and in-person care
por: Glass, Joseph
Publicado: (2015)

The comparative costs of implementing in-person and computerized interventions to enhance treatment receipt among drug-involved probationers
por: Cowell, Alexander J, et al.
Publicado: (2015)

Screening of vascular pathologies – evidence-based monitoring of prevention efficiency
por: Lushchyk, Ulyana B, et al.
Publicado: (2014)

EHMTI-0277. Monitoring the use of symptomatic drugs in headache patients: a 6 month follow-up
por: Voiticovschi-Iosob, C, et al.
Publicado: (2014)

Role of Angiopoietic Coronary Endothelial Dysfunction in the Pathogenesis of Ischemic Cardiomyopathy
por: Chumakova, Svetlana P., et al.
Publicado: (2023)

Antithyroid drugs
por: Jastrzębska, Helena
Publicado: (2015)

Utilizing Roche Cedex Bio analyzer for in process monitoring in biotech production
por: Druhmann, Dörthe, et al.
Publicado: (2011)

IT- technology for vascular monitoring as an evidential base in prevention and prediction of a vascular pathology
por: Lushchyk, Ulyana B, et al.
Publicado: (2014)

Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies
por: Todosenko, Natalia, et al.
Publicado: (2021)

Digital drug discovery
por: Goldman, Michael A
Publicado: (2005)

Aging and drug discovery
por: Bakula, Daniela, et al.
Publicado: (2018)

Allergic diseases of the skin and drug allergies – 2002. Association of food and drug allergy with anti-tuberculosis drug related hepatitis or skin reactions
por: Siribaddana, Anoma, et al.
Publicado: (2013)

The pathogenesis of vasculitis
por: Kallenberg, CGM
Publicado: (2001)

Early detection of cardiovascular instability by monitoring oxygen uptake and carbon dioxide production
por: Pilas, V, et al.
Publicado: (2003)

Cyclopædia of Drug Pathogenesy
Publicado: (1887)

Cyclopædia of Drug Pathogenesy
por: Lippe, Ad.
Publicado: (1885)

Unlicensed drug use on ICU
por: Goldsmith, C, et al.
Publicado: (2002)

The nature of addiction and drug rehabilitation
por: Kaloterakis, Phaedon
Publicado: (2010)

High throughput drug profiling
por: Entzeroth, Michael, et al.
Publicado: (2000)

A strategic thinking of the scientific system of drug regulatory in China - advancing drug standards of China
por: Zhou, Fucheng
Publicado: (2012)

Effect of Glucose Levels on Cardiovascular Risk
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs
por: Aziz, Ramy K, et al.
Publicado: (2011)

Allergic diseases of the skin and drug allergies – 2036. Exanthematous drug eruption to prasugrel: a case report
por: Buddiga, Praveen, et al.
Publicado: (2013)

Meeting report on the Alzheimer’s Drug Discovery Foundation 14th International Conference on Alzheimer’s Drug Discovery
por: Friedman, Lauren G, et al.
Publicado: (2014)

The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs
por: Guzman, Emily, et al.
Publicado: (2018)

Prescription drug monitoring program utilization in Kentucky community pharmacies
por: Wixson, Sarah E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vt8goh63a4g65nesbkukq6d4rp